Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

The phacoemulsification system market has been expanding steadily, driven by advances in eye care technology and shifting patient preferences. As cataract surgeries become more common and minimally invasive methods gain traction, this market is set to experience notable growth through the next decade. Below, we explore the market’s size, key drivers, competitive landscape, and emerging trends shaping its future.

Phacoemulsification System Market Size and Growth Trajectory

The market for phacoemulsification systems has shown remarkable progress in recent years. It is forecasted to increase from $1.51 billion in 2025 to $1.63 billion in 2026, with a compound annual growth rate (CAGR) of 7.6%. This growth during the historical period is largely attributed to the rising incidence of cataracts, an aging global population, wider adoption of phacoemulsification techniques, expansion of ophthalmic care infrastructure, and surgeons’ preference for minimally invasive tools. Looking ahead, the market is expected to reach $2.16 billion by 2030, growing at a CAGR of 7.3%, driven by factors such as increased outpatient eye surgeries, innovative ultrasound technologies, demand for premium intraocular lenses (IOLs), expanding emerging markets, and growing awareness of eye health. Key trends anticipated in the forecast period include advanced fluidics control, broader adoption of minimally invasive cataract surgery, precise ultrasonic energy delivery, shorter procedure times, and enhanced patient safety.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30352&type=smp

Rising Popularity of Minimally Invasive Ophthalmic Procedures Boosts Market Demand

The growing preference for minimally invasive ophthalmic procedures is a major catalyst in the phacoemulsification system market’s expansion. These procedures use small incisions and micro-instruments or lasers to treat eye conditions, minimizing tissue damage. Patients benefit from faster recoveries and less surgical trauma, which has fueled demand for such advanced techniques. The phacoemulsification system plays a vital role by employing ultrasonic energy to break up and remove cataracts through tiny incisions, enabling quicker healing and more precise surgery. For example, in May 2024, Gov.UK reported that there were 516,073 hospital admissions for cataract surgery in England among individuals aged 65 and above, a rate of 4,679 per 100,000 population in 2023. This data highlights the increasing uptake of minimally invasive eye surgeries, supporting market growth.

Expanding Outpatient Surgeries and Technological Innovation Drive Market Momentum

Another factor propelling the phacoemulsification system market is the rise in outpatient eye surgeries, making procedures more accessible and cost-effective. Technological advancements in ultrasound systems and the growing demand for premium IOLs further stimulate market expansion. Additionally, as emerging markets develop their ophthalmic infrastructure and vision care awareness spreads, opportunities for market growth multiply. Manufacturers are innovating with features such as enhanced fluidics control and smarter ultrasonic energy delivery, which improve surgical outcomes and patient safety.

Access The Complete Phacoemulsification System Market Report:

https://www.thebusinessresearchcompany.com/report/global-phacoemulsification-system-market-report

Detailed Segmentation of the Phacoemulsification System Market

This market is segmented based on product type, application, and end-user categories. The product range includes standalone phacoemulsification systems and portable models. Applications cover cataract surgery, refractive lens exchange (RLE), and secondary lens removal procedures. End-users are primarily hospitals, ophthalmic clinics, ambulatory surgical centers, and a variety of other medical facilities. Subcategories within standalone systems include ultrasonic handpiece units, control consoles, fluid management units, and illumination modules. Portable systems feature battery-powered units, compact consoles, handheld devices, and mobile surgical kits. This detailed classification provides insight into market dynamics and areas of strategic focus.

Innovations and Emerging Trends Shaping Market Expansion

Leading companies in the phacoemulsification system market are increasingly integrating femtosecond laser technology and novel fluidics concepts to enhance surgical precision. These fluidics systems regulate irrigation and aspiration during surgery to maintain stable intraocular pressure (IOP) and chamber stability. For example, in September 2025, US-based Beaver-Visitec International, Inc. introduced Virtuoso, a dual-function phaco-vitrectomy platform designed for cataract and vitreoretinal surgeries. This system features advanced fluidics technology to maintain target IOP at every surgical stage, a hybrid pump design for better chamber stability, and Load Sensing Phaco technology that adjusts ultrasound energy in real-time based on lens resistance, improving efficiency and safety.

Key Market Players Steering Industry Competition

The phacoemulsification system market is shaped by a number of major companies including Alcon, Johnson & Johnson, Bausch + Lomb, NIDEK, Oertli Instrumente, Optikon, Geuder, Appasamy Associates, Biotech Visioncare, Meda, SIFI, Ziemer Ophthalmic Systems, Topcon, Carl Zeiss Meditec, Huvitz, Rumex International, DORC International, MicroSurgical Technology, LIGHTMED, Aurolab, and MTP Medical Technical Products. These organizations are driving innovation, expanding product offerings, and competing to capture a larger share of this growing market.

Regional Market Dominance and Growth Opportunities

In 2025, North America held the leading position in the phacoemulsification system market. However, over the forecast period, Asia-Pacific is anticipated to be the fastest-growing region due to rising healthcare investments, increasing cataract prevalence, and expanding ophthalmic infrastructure. The comprehensive market analysis encompasses regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a global view of market dynamics and growth potential.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model